Abstract
Allosteric modulators have emerged with many potential pharmacological advantages as they do not compete the binding of agonist or antagonist to the orthosteric sites but ultimately affect downstream signaling. To identify allosteric modulators targeting an extra-helical binding site of the glucagon-like peptide-1 receptor (GLP-1R) within the membrane environment, the following two computational approaches were applied: structure-based virtual screening with consideration of lipid contacts and ligand-based virtual screening with the maintenance of specific allosteric pocket residue interactions. Verified by radiolabeled ligand binding and cAMP accumulation experiments, two negative allosteric modulators and seven positive allosteric modulators were discovered using structure-based and ligand-based virtual screening methods, respectively. The computational approach presented here could possibly be used to discover allosteric modulators of other G protein-coupled receptors.
| Original language | English |
|---|---|
| Article number | 929 |
| Pages (from-to) | 1-14 |
| Number of pages | 14 |
| Journal | Biomolecules |
| Volume | 11 |
| Issue number | 7 |
| Early online date | 23 Jun 2021 |
| DOIs | |
| Publication status | Published - Jul 2021 |
Bibliographical note
This article belongs to the Special Issue: Design, Synthesis and Structure of Peptides.Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
Funding
Funding: This research was partially supported by National Key Research and Development Program of China grants 2018YFA0507000 (S.Z. and M.-W.W.) and 2016YFC0905900 (S.Z.); National Mega R&D Program for Drug Discovery grants 2018ZX09711002-002-005 (D.Y.) and 2018ZX09735-001 (M.-W.W); National Natural Science Foundation of China grants 21704064 (Q.Z.), 81573479 (D.Y.), 81773792 (D.Y.), 81872915 (M.-W.W.), 82073904 (M.-W.W.) and 31971178 (S.Z.); Shanghai Science & Technology Development Fund grant 16ZR1407100 (A.D.); Novo Nordisk-CAS Research Fund grant NNCAS-2017-1-CC (D.Y.) and annual overhead support from ShanghaiTech University and Chinese Academy of Sciences.
| Funders | Funder number |
|---|---|
| National Mega R&D Program for Drug Discovery | 2018ZX09735-001, 2018ZX09711002-002-005 |
| Novo Nordisk-CAS Research | 8e1v8e7l2o9p1m5 |
| Novo Nordisk-CAS Research Fund | NNCAS-2017-1-CC |
| ShanghaiTech University enFcuen | |
| Shanghai Science and Technology Development Foundation | |
| National Natural Science Foundation of China | 21704064, 31971178, 81872915, 16ZR1407100, 81773792, 82073904, 81573479 M0e0g1a |
| Chinese Academy of Sciences | |
| National Key Research and Development Program of China | 2016YFC0905900, 2018YFA0507000 |
| ShanghaiTech University |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Allosteric modulator
- Drug discovery
- GLP-1R
- Molecular docking
- Virtual screening
Fingerprint
Dive into the research topics of 'Discovery of novel allosteric modulators targeting an extra-helical binding site of glp-1r using structure-and ligand-based virtual screening'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver